Title |
miR-30c and miR-181a synergistically modulate p53–p21 pathway in diabetes induced cardiac hypertrophy
|
---|---|
Published in |
Molecular and Cellular Biochemistry, May 2016
|
DOI | 10.1007/s11010-016-2729-7 |
Pubmed ID | |
Authors |
Satish K. Raut, Gurinder B. Singh, Bhawna Rastogi, Uma Nahar Saikia, Anupam Mittal, Nilambra Dogra, Sandeep Singh, Rishikesh Prasad, Madhu Khullar |
Abstract |
p53-p21 pathway mediates cardiomyocyte hypertrophy and apoptosis and is upregulated in diabetic cardiomyopathy (DbCM). We investigated role of microRNAs in regulating p53-p21 pathway in high glucose (HG)-induced cardiomyocyte hypertrophy and apoptosis. miR-30c and miR-181a were identified to target p53. Cardiac expression of microRNAs was measured in diabetic patients, diabetic rats, and in HG-treated cardiomyocytes. Effect of microRNAs over-expression and inhibition on HG-induced cardiomyocyte hypertrophy and apoptosis was examined. Myocardial expression of p53 and p21 genes was increased and expression of miR-30c and miR-181a was significantly decreased in diabetic patients, DbCM rats, and in HG-treated cardiomyocytes. Luciferase assay confirmed p53 as target of miR-30c and miR-181a. Over-expression of miR-30c or miR-181a decreased expression of p53, p21, ANP, cardiomyocyte cell size, and apoptosis in HG-treated cardiomyocytes. Concurrent over-expression of these microRNAs resulted in greater decrease in cardiomyocyte hypertrophy and apoptosis, suggesting a synergistic effect of these microRNAs. Our results suggest that dysregulation of miR-30c and miR-181a may be involved in upregulation of p53-p21 pathway in DbCM. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 3 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Science communicators (journalists, bloggers, editors) | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 46 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 15% |
Student > Master | 5 | 11% |
Student > Ph. D. Student | 5 | 11% |
Student > Postgraduate | 3 | 7% |
Student > Doctoral Student | 3 | 7% |
Other | 6 | 13% |
Unknown | 17 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 8 | 17% |
Medicine and Dentistry | 8 | 17% |
Agricultural and Biological Sciences | 4 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 7% |
Immunology and Microbiology | 1 | 2% |
Other | 2 | 4% |
Unknown | 20 | 43% |